Cargando…
Structure-based mutational analysis of ICAT residues mediating negative regulation of β-catenin co-transcriptional activity
ICAT (Inhibitor of β-CAtenin and TCF) is a small acidic protein that negatively regulates β-catenin co-transcriptional activity by competing with TCF/LEF factors in their binding to β-catenin superhelical core. In melanoma cells, ICAT competes with LEF1 to negatively regulate the M-MITF and NEDD9 ta...
Autores principales: | Domingues, Mélanie J., Martinez-Sanz, Juan, Papon, Laura, Larue, Lionel, Mouawad, Liliane, Bonaventure, Jacky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342195/ https://www.ncbi.nlm.nih.gov/pubmed/28273108 http://dx.doi.org/10.1371/journal.pone.0172603 |
Ejemplares similares
-
Overexpression of ICAT Inhibits the Progression of Colorectal Cancer by Binding with β-Catenin in the Cytoplasm
por: Hu, Jiancong, et al.
Publicado: (2021) -
Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex
por: Jiang, Yayun, et al.
Publicado: (2017) -
Opposing roles of ICAT and Wnt/β-catenin signaling in NSC67657-induced monocytic differentiation
por: Wang, Weijia, et al.
Publicado: (2017) -
MiR-29b controls fetal mouse neurogenesis by regulating ICAT-mediated Wnt/β-catenin signaling
por: Shin, J, et al.
Publicado: (2014) -
Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction
por: Huang, Rui, et al.
Publicado: (2021)